Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis

JAMA

Volumn 284, Issue 11, 2000, Pages 1417-1424

  Wu, Yvonne W ^a,b   Colford, John M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBRAL PALSY; CHORIOAMNIONITIS; CLINICAL TRIAL; HUMAN; LEUKOMALACIA; META ANALYSIS; OBSERVER VARIATION; OUTCOMES RESEARCH; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0034692557     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.11.1417     Document Type: Review

References (83)

1. Impact of improved survival of very low birth weight infants on recent secular trends in the prevalence of cerebral palsy
2. Intrapartum asphyxia: A rare cause of cerebral palsy
3. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: Medicolegal issues
4. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn
5. Infectious diseases in pregnancy, cytokines and neurological impairment: An hypothesis
6. Maternal infection and cerebral palsy in infants of normal birth weight
7. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity
8. Inflammatory lesions of the human placenta, I: Clinical significance of acute chorioamnionitis
9. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants
10. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant
11. Neonatal cytokines and coagulation factors in children with cerebral palsy
12. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy
13. Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children
14. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants
15. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage
16. Cerebral palsy in very low birth-weight infants
17. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants
18. Intrauterine infection and cerebral palsy in preterm children
19. Cerebral palsy in preterm infants: A population based analysis of antenatal risk factors
20. Predictors of low and very low birth weight and the relation of these to cerebral palsy
21. Antecedents of cerebral palsy, I: Univadate analysis of risks
22. White matter damage in preterm newborns - An epidemiologic perspective
23. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants
24. Cerebral palsy
25. On estimating the relation between blood group and disease
26. Cerebral palsy in Saudi Arabia: A case-control study of risk factors
27. Obstetric risk factors for periventricular leukomalacia among preterm infants
28. Antecedents of infantile cerebral palsy
29. Placental abnormalities: Insights into pathogenesis of cystic periventricular leukomalacia
30. Statistical aspects of the analysis of data from retrospective studies of disease
31. Meta-analysis, decision analysis, and cost-effectiveness
32. Ultrasound findings and clinical antecedents of cerebral palsy in very preterm infants
33. Neonatal risk factors for cerebral palsy in very preterm babies: Case-control study
34. Antenatal and delivery risk factors simultaneously associated with neonatal death and cerebral palsy in preterm infants
35. Prenatal events and the risk of cerebral palsy in very low birth weight infants
36. Antenatal origin of neurologic damage in newborn infants, I: Preterm infants
37. Etiology of congenital cerebral palsy
38. Obstetric antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate
39. Perinatal risk factors for the development of extensive cystic leukomalacia
40. The etiology of cerebral palsy in pre-term infants
41. A study of the association of factors of pregnancy and parturition with the development of cerebral palsy
42. Cerebral palsy and neonatal encephalopathy
43. Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage
44. Cerebral palsy - An etiological study
45. Obstetric factors in cerebral palsy
46. Placental pathology in cases of cystic periventricular leukomalacia
47. Obstetric factors in cerebral palsy, a North Carolina study
48. Etiological factors in cerebral palsy and their correlation with various clinical entities
49. Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm delivery
50. Prospecrive evaluation of perinatal risk factors for cerebral palsy and delayed development in high risk infants
51. Bilateral cystic periventricular leukomalacia in the premature infant: Associated risk factors
52. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants
53. Periventricular leukomalacia: Risk factors revisited
54. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation
55. The etiology of cerebral palsy
56. Urinary tract infection during pregnancy: A risk factor for cerebral palsy?
57. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies
58. Postnatal white matter necrosis in preterm infants
59. Antenatal antecedents of moderate and severe cerebral palsy
60. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration
61. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and matemal compartments
62. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
63. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium
64. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological
65. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits
66. Intraamniotic inflammation and the development of cerebral palsy at three years of age
67. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia
68. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia
69. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia
70. Risk factors for fever in labor
71. Brain injury in the premature infant - From pathogenesis to prevention
72. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth-weight infants?
73. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight
74. Modification of the infection-associated risks of preterm birth and white matter damage in the preterm newborn by polymorphisms in the tumor necrosis factor-locus?
75. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes
76. Prenatal and perinatal factors in the etiology of cerebral palsy
77. Risk factors for cerebral palsy: A case-control study in Greece